Exact Sciences today announced it will sell 4 million shares of its common stock at $25.75 per share until Friday.

According to a release, the company intends to use the net proceeds to fund expansion of Cologuard commercialization activities, to fund product development efforts and for general corporate and working capital purposes.

Jefferies LLC and Robert W. Baird & Co. Incorporated, which are acting as the underwriters, have an option to purchase up to 600,000 additional shares, Exact Sciences said.